Elegen

Product Manager

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Software, Product ManagementIndustries

Requirements

Candidates should possess at least 2 years of experience as a Product Manager, preferably in a B2B/SaaS environment, and demonstrate intermediate to advanced English skills for written communication. A background in a startup or fast-paced agency is preferred, along with experience working with cross-functional teams.

Responsibilities

The Product Manager will conduct market research to identify competitors and define the platform’s approach, translate business needs into structured documentation such as PRDs and flows, collaborate with UI/UX designers and developers to build an MVP, manage the product backlog, set priorities, track sprints, test features and iterate based on user feedback, and ultimately take full ownership of the platform from concept to MVP and beyond.

Skills

Market Research
Competitive Analysis
PRD
User Feedback
Product Backlog Management
Sprint Management
UI/UX Collaboration
Cross-functional Teamwork
MVP Development

Elegen

Custom DNA synthesis for biotech applications

About Elegen

Elegen focuses on improving the process of manufacturing synthetic DNA to meet the needs of the bioeconomy. The company provides custom DNA synthesis services to researchers, biotech companies, and pharmaceutical firms that require high-quality and complex synthetic DNA for various applications, including biomanufacturing and mRNA-based treatments. Elegen uses advanced technologies to ensure fast turnaround times and high accuracy in DNA synthesis, which are essential for its clients' projects. Unlike its competitors, Elegen not only streamlines traditional DNA manufacturing workflows but also enables the production of valuable biologics and therapeutics. The company's goal is to support the development of next-generation mRNA medicines and other advanced therapeutics by providing reliable and efficient DNA solutions.

Key Metrics

San Carlos, CaliforniaHeadquarters
2017Year Founded
$34MTotal Funding
SERIES_BCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Short Term Disability
Long Term Disability
Parental Leave
Commuter Benefits
Fitness Allowance
Learning Allowance

Risks

Increased competition from companies like Twist Bioscience in DNA synthesis capabilities.
Potential intellectual property disputes could impact Elegen's proprietary technologies.
Dependence on key partnerships, like GSK, could affect market position if dissolved.

Differentiation

Elegen's ENFINIA™ DNA offers rapid synthesis of highly complex DNA in 10 days.
The company provides cell-free DNA production, reducing contamination risks and improving efficiency.
Elegen's Early Access Program allows clients early access to high-complexity DNA breakthroughs.

Upsides

Elegen raised $35M to expand its ENFINIA™ DNA product line for clinical development.
Collaboration with GSK enhances Elegen's cell-free DNA technology for vaccines and medicines.
Elegen's ability to synthesize complex DNA sequences gives it a competitive market edge.

Land your dream remote job 3x faster with AI